These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes. Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Spiegel HE; Symington J; Christian R; Moore JD; Weissman L; Kaplan SA J Pharmacokinet Biopharm; 1977 Feb; 5(1):3-23. PubMed ID: 845790 [No Abstract] [Full Text] [Related]
25. [Biologic availability and "1st pass" effect of drugs]. Rietbrock N; Keller F Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146 [TBL] [Abstract][Full Text] [Related]
26. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Dokoumetzidis A; Macheras P Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290 [TBL] [Abstract][Full Text] [Related]
27. Tissue damage and concentration at the injection site after intramuscular injection of chemotherapeutics and vehicles in pigs. Rasmussen F; Svendsen O Res Vet Sci; 1976 Jan; 20(1):55-60. PubMed ID: 1257628 [TBL] [Abstract][Full Text] [Related]
28. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers. Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014 [TBL] [Abstract][Full Text] [Related]
29. Bioavailability study of gitoxin in a solid dosage form. Hupin C; de Suray JM; Versluys J; Lorent M; Dodion L; Lesne M Int J Clin Pharmacol Biopharm; 1979 May; 17(5):197-204. PubMed ID: 468445 [TBL] [Abstract][Full Text] [Related]
30. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model. Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304 [TBL] [Abstract][Full Text] [Related]
31. [Creatine phosphokinase, myocardial infarction and intramuscular injection]. Sauerwein HP; Brouwer T; Dunning AJ Ned Tijdschr Geneeskd; 1975 Sep; 119(37):1399-402. PubMed ID: 1178074 [No Abstract] [Full Text] [Related]
32. Effect of formulation on dissolution and bioavailability of phenytoin tablets. Chakrabarti S; Belpaire F; Moerman E Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745 [TBL] [Abstract][Full Text] [Related]
34. Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions. Korttila K; Sothman A; Andersson P Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):104-17. PubMed ID: 782157 [No Abstract] [Full Text] [Related]
35. Effect of particle size of parenteral suspensions on in vitro muscle damage. Brazeau G; Sauberan SL; Gatlin L; Wisniecki P; Shah J Pharm Dev Technol; 2011; 16(6):591-8. PubMed ID: 21214423 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of distribution and metabolism of diazepam and chlordiazepoxide in mice. van der Kleijn E Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):193-215. PubMed ID: 5353471 [No Abstract] [Full Text] [Related]
37. Proceedings: Some factors influencing the absorption of diazepam. Gamble JA Proc R Soc Med; 1975 Dec; 68(12):772. PubMed ID: 1219748 [No Abstract] [Full Text] [Related]